TWB-103 for Treating Lower Limb Ulcers on Patients With DM
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Transwell Biotech Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT03624023
- Locations
- π¨π³
Tri-Service General Hospital, Taipei, Taiwan
π¨π³National Taiwan University Hospital, Taipei, Taiwan
TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds
Phase 1
Completed
- Conditions
- Donor Site Complication
- Interventions
- Drug: TWB-103 GroupDrug: Placebo Group
- First Posted Date
- 2016-04-14
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Transwell Biotech Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02737748
- Locations
- π―π΅
Nippon Medical School, Tokyo, Japan
π¨π³Tri-Service General Hospital, Taipei, Taiwan
π―π΅Tokyo Medical University, Tokyo, Japan
Β© Copyright 2025. All Rights Reserved by MedPath